Kaiwen Wang

443 total citations
13 papers, 272 citations indexed

About

Kaiwen Wang is a scholar working on Epidemiology, Rheumatology and Molecular Biology. According to data from OpenAlex, Kaiwen Wang has authored 13 papers receiving a total of 272 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 7 papers in Rheumatology and 4 papers in Molecular Biology. Recurrent topics in Kaiwen Wang's work include Inflammatory Myopathies and Dermatomyositis (9 papers), Systemic Sclerosis and Related Diseases (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Kaiwen Wang is often cited by papers focused on Inflammatory Myopathies and Dermatomyositis (9 papers), Systemic Sclerosis and Related Diseases (4 papers) and Eosinophilic Disorders and Syndromes (3 papers). Kaiwen Wang collaborates with scholars based in China, United States and Germany. Kaiwen Wang's co-authors include Shuang Ye, Li Guo, Wenwen Xu, Wanlong Wu, Danting Zhang, Zhiwei Chen, Yakai Fu, Xiaodong Wang, Yu Zheng and Zhiwei Chen and has published in prestigious journals such as Scientific Reports, Frontiers in Immunology and British Journal of Dermatology.

In The Last Decade

Kaiwen Wang

12 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kaiwen Wang China 7 205 147 97 73 48 13 272
Mirei Shirakashi Japan 9 124 0.6× 126 0.9× 79 0.8× 63 0.9× 22 0.5× 30 261
Gianfranco Vitiello Italy 8 68 0.3× 91 0.6× 42 0.4× 45 0.6× 21 0.4× 23 208
Yakai Fu China 8 145 0.7× 113 0.8× 66 0.7× 52 0.7× 26 0.5× 17 248
Youhei Fujiki Japan 11 143 0.7× 141 1.0× 129 1.3× 51 0.7× 26 0.5× 23 269
Kévin Didier France 6 55 0.3× 138 0.9× 41 0.4× 95 1.3× 18 0.4× 8 281
Hanxiao You China 7 67 0.3× 104 0.7× 32 0.3× 63 0.9× 26 0.5× 21 217
Takahiro Nunokawa Japan 8 101 0.5× 85 0.6× 117 1.2× 18 0.2× 21 0.4× 24 218
Adrianne Woods United States 6 68 0.3× 57 0.4× 86 0.9× 152 2.1× 28 0.6× 10 283
Françoise Fortenfant France 9 59 0.3× 87 0.6× 41 0.4× 30 0.4× 8 0.2× 31 239

Countries citing papers authored by Kaiwen Wang

Since Specialization
Citations

This map shows the geographic impact of Kaiwen Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kaiwen Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kaiwen Wang more than expected).

Fields of papers citing papers by Kaiwen Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kaiwen Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kaiwen Wang. The network helps show where Kaiwen Wang may publish in the future.

Co-authorship network of co-authors of Kaiwen Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Kaiwen Wang. A scholar is included among the top collaborators of Kaiwen Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kaiwen Wang. Kaiwen Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Fu, Yakai, Zhiwei Chen, Jie Chen, et al.. (2025). Efficacy of JAK inhibitor combined with protein A immunoadsorption in MDA5+ dermatomyositis with RPILD: A real-world study. Med. 6(10). 100802–100802. 1 indexed citations
3.
Wang, Kaiwen, Xuemei Feng, Jia Li, et al.. (2024). PD-1/PD-L1 governed cross-talk of exhausted CD8+ T and memory B cells in systemic lupus erythematosus. RMD Open. 10(1). e003503–e003503. 3 indexed citations
5.
Wang, Juan, Lihui Lin, Peng Xia, et al.. (2023). LncRNA-Anrel promotes the proliferation and migration of synovial fibroblasts through regulating miR-146a-mediated annexin A1 expression.. PubMed. 12(4). 49–59. 3 indexed citations
6.
Guo, Li, Xueliang Zhang, Weilin Pu, et al.. (2023). WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease. Lara D. Veeken. 62(6). 2320–2324. 14 indexed citations
7.
Wu, Wanlong, et al.. (2023). Janus kinase inhibitor for anti-transcription intermediary factor 1-γ positive cancer-associated dermatomyositis. British Journal of Dermatology. 190(2). 285–287. 2 indexed citations
8.
Xu, Wenwen, Wanlong Wu, Yu Zheng, et al.. (2021). A Computed Tomography Radiomics-Based Prediction Model on Interstitial Lung Disease in Anti-MDA5-Positive Dermatomyositis. Frontiers in Medicine. 8. 768052–768052. 25 indexed citations
9.
Xu, Wenwen, Wanlong Wu, Danting Zhang, et al.. (2021). A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Scientific Reports. 11(1). 17070–17070. 24 indexed citations
10.
Wang, Kaiwen, Wanlong Wu, Wenwen Xu, et al.. (2021). RNA-Containing Immune Complexes Formed by Anti-Melanoma Differentiation Associated Gene 5 Autoantibody Are Potent Inducers of IFN-α. Frontiers in Immunology. 12. 743704–743704. 21 indexed citations
11.
Wu, Wanlong, Li Guo, Yakai Fu, et al.. (2021). Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clinical Reviews in Allergy & Immunology. 60(2). 293–304. 116 indexed citations
12.
Wang, Kaiwen, Zhiwei Chen, Ting Li, et al.. (2018). CD4+CXCR4+ T cells as a novel prognostic biomarker in patients with idiopathic inflammatory myopathy-associated interstitial lung disease. Lara D. Veeken. 58(3). 511–521. 46 indexed citations
13.
Wang, Kaiwen, Xiaodong Wang, Ting Li, et al.. (2017). The performance of different anti-dsDNA autoantibodies assays in Chinese systemic lupus erythematosus patients. Clinical Rheumatology. 37(1). 139–144. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026